Literature DB >> 19249755

Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome.

Kyung Hee Lee1, Seok Hyun Kim, Byung Chul Jee, Yong Jin Kim, Chang Suk Suh, Ki Chul Kim, Won Don Lee.   

Abstract

OBJECTIVE: To clarify the differences in clinical characteristics between early and late ovarian hyperstimulation syndrome (OHSS).
DESIGN: Retrospective study.
SETTING: Tertiary university hospital. PATIENT(S): Ninety-four patients/cycles hospitalized for moderate-to-severe OHSS after controlled ovarian hyperstimulation (COH) for IVF/intracytoplasmic sperm injection (ICSI); early type (n = 69) and late type (n = 25). INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): The COH and pregnancy outcomes, preclinical and clinical miscarriage rate, and hospital courses. RESULT(S): Serum E(2) levels (4,955.5 +/- 3,268.5 pg/mL vs. 2,340.8 +/- 960.6 pg/mL) and the number of follicles > or =11 mm on day of hCG administration (15.9 +/- 6.0 vs. 13.0 +/- 4.0), and the number of oocytes retrieved (21.9 +/- 9.7 vs. 13.2 +/- 5.9) were significantly higher in the early OHSS group compared with the late OHSS group. Clinical pregnancy rate (PR) was significantly higher in the late OHSS group (23.6% [13/55] vs. 92.0% [23/25]). There were no significant differences in multiple PR and disease severity between the two groups. CONCLUSION(S): Early OHSS is associated with excessive ovarian response to gonadotropin stimulation, whereas late OHSS is closely associated with conception cycle. Our findings do not support that late OHSS is more severe and closely associated with multiple pregnancies compared with early OHSS. Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19249755     DOI: 10.1016/j.fertnstert.2009.01.057

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  A unique human chorionic gonadotropin antagonist suppresses ovarian hyperstimulation syndrome in rats.

Authors:  Pratibhasri A Vardhana; Martin A Julius; Susan V Pollak; Evan G Lustbader; Rhonda K Trousdale; Joyce W Lustbader
Journal:  Endocrinology       Date:  2009-05-14       Impact factor: 4.736

2.  Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study.

Authors:  George T Lainas; Efstratios M Kolibianakis; Ioannis A Sfontouris; Ioannis Z Zorzovilis; George K Petsas; Theoni B Tarlatzi; Basil C Tarlatzis; Trifon G Lainas
Journal:  Reprod Biol Endocrinol       Date:  2012-08-31       Impact factor: 5.211

3.  Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles.

Authors:  Mário Sousa; Mariana Cunha; José Teixeira da Silva; Cristiano Oliveira; Joaquina Silva; Paulo Viana; Alberto Barros
Journal:  Reprod Biol Endocrinol       Date:  2015-06-23       Impact factor: 5.211

4.  High levels estradiol affect blastocyst implantation and post-implantation development directly in mice.

Authors:  Ko-Tung Chang; Yu-Ting Su; Yi-Ru Tsai; Kuo-Chung Lan; Yan-Der Hsuuw; Hong-Yo Kang; Wen-Hsiung Chan; Fu-Jen Huang
Journal:  Biomed J       Date:  2021-01-16       Impact factor: 7.892

5.  Pregnancy Outcomes of In Vitro Fertilization with or without Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study in Chinese Patients.

Authors:  Xuan Jiang; Cheng-Yan Deng; Zheng-Yi Sun; Wei-Lin Chen; Han-Bi Wang; Yuan-Zheng Zhou; Li Jin
Journal:  Chin Med J (Engl)       Date:  2015-12-05       Impact factor: 2.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.